[go: up one dir, main page]

DE102011114094A8 - Stimulierendes und belebendes Nasenspray und Nasentropfen - Google Patents

Stimulierendes und belebendes Nasenspray und Nasentropfen Download PDF

Info

Publication number
DE102011114094A8
DE102011114094A8 DE102011114094A DE102011114094A DE102011114094A8 DE 102011114094 A8 DE102011114094 A8 DE 102011114094A8 DE 102011114094 A DE102011114094 A DE 102011114094A DE 102011114094 A DE102011114094 A DE 102011114094A DE 102011114094 A8 DE102011114094 A8 DE 102011114094A8
Authority
DE
Germany
Prior art keywords
invigorating
stimulating
nasal spray
nose drops
nose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102011114094A
Other languages
English (en)
Other versions
DE102011114094A1 (de
Inventor
Dr. Steinfeld Ute
Frank Holzer
Hyeck-Hee Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Holzer GmbH
Original Assignee
F Holzer GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Holzer GmbH filed Critical F Holzer GmbH
Priority to DE102011114094A priority Critical patent/DE102011114094A1/de
Priority to PCT/EP2012/068688 priority patent/WO2013041696A1/de
Publication of DE102011114094A1 publication Critical patent/DE102011114094A1/de
Publication of DE102011114094A8 publication Critical patent/DE102011114094A8/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE102011114094A 2011-09-21 2011-09-21 Stimulierendes und belebendes Nasenspray und Nasentropfen Withdrawn DE102011114094A1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE102011114094A DE102011114094A1 (de) 2011-09-21 2011-09-21 Stimulierendes und belebendes Nasenspray und Nasentropfen
PCT/EP2012/068688 WO2013041696A1 (de) 2011-09-21 2012-09-21 Stimulierendes und belebendes nasenspray und nasentropfen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102011114094A DE102011114094A1 (de) 2011-09-21 2011-09-21 Stimulierendes und belebendes Nasenspray und Nasentropfen

Publications (2)

Publication Number Publication Date
DE102011114094A1 DE102011114094A1 (de) 2013-03-21
DE102011114094A8 true DE102011114094A8 (de) 2013-06-06

Family

ID=46924430

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102011114094A Withdrawn DE102011114094A1 (de) 2011-09-21 2011-09-21 Stimulierendes und belebendes Nasenspray und Nasentropfen

Country Status (2)

Country Link
DE (1) DE102011114094A1 (de)
WO (1) WO2013041696A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140323505A1 (en) * 2013-04-25 2014-10-30 Rinsenergy LLC Oral rinse composition and method to deliver energy supplements
WO2020141180A1 (en) * 2018-12-31 2020-07-09 Philip Morris Products S.A. Liquid nicotine formulation
EP3991573A1 (de) 2020-11-03 2022-05-04 Patrick Faber Zusammensetzungen zur nasalen applikation

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003128583A (ja) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd 清涼化組成物
US20060120967A1 (en) * 2004-12-07 2006-06-08 Qpharma, Llc Solution forms of cyclodextrins for nasal or throat delivery of essential oils
DE202007007584U1 (de) * 2007-05-29 2007-08-02 Day-Med-Concept Gmbh Flüssigformulierung enthaltend fettlösliche Verbindungen als Solubilisat
WO2009001085A2 (en) * 2007-06-25 2008-12-31 Kind Consumer Limited An inhalable composition comprising nicotine
US20090069433A1 (en) * 2007-09-10 2009-03-12 Wayne Jeffrey Perry Nasal rinse additive
DE202010012255U1 (de) * 2010-09-07 2010-11-18 Krewel Meuselbach Gmbh Nasenspray

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2507445B2 (ja) 1987-06-23 1996-06-12 住友電気工業株式会社 光コネクタコ−ドの製造方法
JPH0640906A (ja) 1992-07-22 1994-02-15 Suntory Ltd 眠気抑制剤
MA23588A1 (fr) * 1994-06-23 1995-12-31 Procter & Gamble Traitement du besoin en nicotine et/ou du syndrome de manque lie au tabagisme
US6350458B1 (en) * 1998-02-10 2002-02-26 Generex Pharmaceuticals Incorporated Mixed micellar drug deliver system and method of preparation
WO2001001982A1 (en) * 1999-07-02 2001-01-11 Nippon Chemical Works Co., Ltd. Aminoethanesulfonic acid-containing preparations
EP1346726A4 (de) 2000-12-25 2004-09-15 Shiseido Co Ltd Parfumzusammenstellung die das sympathetische system stimulieren
US20080268092A1 (en) * 2004-12-01 2008-10-30 Dacanay Rhodel G Capsaicin Nutritional Supplement
CN1285382C (zh) * 2004-12-20 2006-11-22 凌沛学 含海藻糖和玻璃酸的鼻腔用药传递系统及其制备方法
FR2895260B1 (fr) * 2005-12-23 2009-02-20 Servier Lab Nouvelle composition pharmaceutique a base d'huile essentielle pour pulverisation nasale et/ou buccale
DE202008016517U1 (de) * 2008-12-12 2009-03-05 Ratiopharm Gmbh Wässrige Zusammensetzung enthaltend Dexpanthenol und Natriumchlorid
US20110053988A1 (en) * 2009-08-29 2011-03-03 Jorge Alberto Cassara Low-dose, non-irritating nicotine nasal composition to reduce the desire to smoke

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003128583A (ja) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd 清涼化組成物
US20060120967A1 (en) * 2004-12-07 2006-06-08 Qpharma, Llc Solution forms of cyclodextrins for nasal or throat delivery of essential oils
DE202007007584U1 (de) * 2007-05-29 2007-08-02 Day-Med-Concept Gmbh Flüssigformulierung enthaltend fettlösliche Verbindungen als Solubilisat
WO2009001085A2 (en) * 2007-06-25 2008-12-31 Kind Consumer Limited An inhalable composition comprising nicotine
US20090069433A1 (en) * 2007-09-10 2009-03-12 Wayne Jeffrey Perry Nasal rinse additive
DE202010012255U1 (de) * 2010-09-07 2010-11-18 Krewel Meuselbach Gmbh Nasenspray

Also Published As

Publication number Publication date
DE102011114094A1 (de) 2013-03-21
WO2013041696A1 (de) 2013-03-28

Similar Documents

Publication Publication Date Title
SG10201500954WA (en) Therapeutic canine immunoglobulins and methods of using the same
SMT201500114B (it) Dispositivo per spray nasale
ZA201205829B (en) Treatment of respiratory disorders
PL2739268T3 (pl) Sposób i formulacja do inhalacji
SG10201607576PA (en) Devices for treating nasal airways
IL234508B (en) Inhalation of nitric oxide for treating respiratory diseases
LT2796132T (lt) Neurologinių sutrikimų terapija baklofeno ir akamprosato pagrindu
ZA201403372B (en) Therapeutic agents and uses thereof
EP2877133A4 (de) Verbesserungen an nasalen dilatationsvorrichtungen
IL221873A (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd
DK2747763T3 (da) (bacterio-)chlorofyllfotosensibilisatorer til behandling af øjensygdomme og -lidelser
EP2682145A4 (de) Spritze und spritzenanordnung
PL2613793T3 (pl) Aerozol do nosa
AU339359S (en) Respiratory mask and/or components thereof
ZA201400167B (en) Treatment of respiratory disorders using trpa1 antagonists
AU340344S (en) Atomizing nozzle for nasal therapy
BR112013034066A2 (pt) método de administração e tratamento
PL2780003T3 (pl) Leczenie niedoczynności kory nadnerczy
DE102011114094A8 (de) Stimulierendes und belebendes Nasenspray und Nasentropfen
HUE036419T2 (hu) Légzõszervi depresszió kezelése
DK2694056T3 (da) Terapeutisk behandling
IL232944A0 (en) Formulation for nasal administration
EP2726505A4 (de) Therapeutisches targeting von ficolin-3
GB2504889B (en) Therapeutic canine immunoglobulins and methods of using the same
GB201001912D0 (en) Treatment of respiratory disorders

Legal Events

Date Code Title Description
R012 Request for examination validly filed
R082 Change of representative

Representative=s name: PFENNING, MEINIG & PARTNER MBB PATENTANWAELTE, DE

Representative=s name: PFENNING MEINIG & PARTNER GBR, DE

R016 Response to examination communication
R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee
R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Effective date: 20150401